Magnesium aspartate dihydrate

Amber-G

Brand Name(s):Magnaspartate

Indication:Hypomagnesaemia

Rationale:

Considered:Apr-15

Review Date:Apr-20

Comments:
Primary Care must receive a comprehensive treatment plan before prescribing is transfered to the GP including:

Treatment should be initiated under the supervision of a physician experienced in the management of hypomagnesaemia.
A detailed clinical management plan must be provided by the Specialist which includes details on:
(a) Review and followup process
(b) Therapeutic monitoring process

April 2015